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We screened automated ambulatory medical records, hospital and emer-
gency room claims, and pharmacy records of 2,826 health maintenance
organization (HMO) members who gave birth over a 30-month period. Full-
text ambulatory records were reviewed for the 30-day postpartum period to
confirm infection status for a weighted sample of cases. The overall post-
partum infection rate was 6.0%, with rates of 7.4% following cesarean sec-
tion and 5.5% following vaginal delivery. Rehospitalization; cesarean
delivery; antistaphylococcal antibiotics; diagnosis codes for mastitis,
endometritis, and wound infection; and ambulatory blood or wound cultures
were important predictors of infection. Use of automated information rou-
tinely collected by HMOs and insurers allows efficient identification of post-
partum infections not detected by conventional surveillance. 
The epidemiology of postpartum infections has not been
well characterized. In part this is because of the limitations
of surveillance systems, which usually monitor infections
that are recognized during hospitalization. Most postpartum
and nonobstetrical postsurgical infections, however, occur
after hospital discharge (1-3). Decreasing lengths of hospital
stay may further compromise detection of these infections. 
Several methods for postdischarge surveillance of post-
partum infections have been evaluated. Hulton et al. (1) used
physician questionnaires for postdischarge surveillance of
patients undergoing cesarean section. With only inpatient
surveillance, 59% of postpartum infections they ultimately
detected would not have been identified. The overall infec-
tion rate after postdischarge surveillance was implemented
was fourfold higher than the previous rate (6.3% vs. 1.6%).
Holbrook et al. (2) used patient self-administered question-
naires to conduct large-scale, routine postdischarge surveil-
lance following vaginal delivery or cesarean section. Despite
a modest return of questionnaires, self-reported question-
naire results identified twice as many apparent postpartum
infections (4% infection rate) as did concurrent prospective
in-hospital surveillance. Only 48% of reported maternal
infections, however, were confirmed by questionnaires to the
patients’ physicians. Sands et al. (3) evaluated the use of
automated ambulatory diagnosis, testing, and pharmacy
code screening combined with discharge diagnoses to identify
surgical site infections in nonobstetric patients undergoing
surgery. They found that ambulatory code screening was a
sensitive method for detecting patients with surgical site
infections and that 84% occurred after hospital discharge. Of
the postdischarge surgical site infections, most (63%) were
diagnosed and treated entirely in the ambulatory setting. In
addition, patient and surgeon questionnaires had low sensi-
tivities (28% and 15%, respectively) for identifying postdis-
charge infections.
Routine surveillance for nosocomial infections is recom-
mended by the Centers for Disease Control and Prevention
and required by the Joint Commission on Accreditation of
Healthcare Organizations, with the goal of using this infor-
mation to compare infection rates over time and between
institutions and to guide the allocation of resources towards
improvements most likely to result in reduced infection
rates.
In this study, we used the inpatient and outpatient data
collected by a health maintenance organization (HMO) to
identify postpartum infections and describe the epidemiology
of these infections. 
Methods
The study population consisted of all women who had a
vaginal delivery or cesarean section at Brigham and
Women’s Hospital from January 1, 1993, to June 30, 1995,
and who received postpartum care at Harvard Pilgrim
Health Care (HPHC)/Harvard Vanguard Medical Associates
(HVMA) centers with automated full-text ambulatory medi-
cal records. HPHC is a multimodel health maintenance orga-
nization that included a staff model division (now a
multispecialty group practice, HVMA) with approximately
300,000 members in the greater Boston area at the time of
the study. Brigham and Women’s Hospital is the most active
obstetrical facility for these members.
HMO data included three sources: an extensively auto-
mated ambulatory record, pharmacy dispensing data, and
administrative claims for hospital, emergency room, and
other care delivered outside the health center. The auto-
mated ambulatory medical record system (4) used standard-
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ized forms that were completed for every patient encounter
at HPHC/HVMA centers, including telephone calls, office
visits (scheduled or unscheduled), urgent care visits, and
hospitalizations. Information was recorded on forms that are
customized for the type of encounter. The provider either
wrote in or selected from a list of all coded diagnoses, tests,
procedures, and prescriptions relevant to that encounter and
enters additional comments as free text. All information,
including free text, is entered into an automated medical
encounter record. The results of diagnostic tests are entered
directly into the automated record linked to the patient
encounter during which they were ordered. Information
about hospitalizations and emergency room visits appears in
both encounter records and separate administrative records.
HPHC/HVMA pharmacies are also computerized and linked
to the automated medical record. Ninety percent of HPHC
members had prepaid coverage for pharmaceuticals and so
are likely to use HPHC/HVMA pharmacies.
Identification of Postpartum Infections
Automated medical records, pharmacy dispensing
records, and hospital and emergency room claims were
screened by a computerized search of HPHC records for the
30 days following delivery for the presence of any of 32 diag-
nostic, testing, or pharmacy dispensing codes indicative of
postpartum infections (Table 1), as described (3).
Full-text ambulatory medical records and relevant hos-
pital records were reviewed for the 30-day postpartum
period for a random sample of 100 patients with at least one
of the ambulatory screening codes. Surgical site infections
(including endometritis), episiotomy site infections, mastitis,
and urinary tract infections were confirmed by the Centers
for Disease Control and Prevention’s National Nosocomial
Infection Surveillance system definitions (5,6).
Infection rates for the entire study population of post-
partum women were extrapolated by standard methods from
the estimated infection rates for the sample of individual
medical records reviewed (7).
Two previously described surveillance screening meth-
ods were used to assess the completeness of postpartum
infection detection. In one method, patient self-reported
questionnaires were mailed to all women approximately 6
weeks after their infants were discharged, by using previ-
ously described instruments (2). These self-administered
questionnaires asked whether the mother had specific infec-
tions, received an antibiotic, or was rehospitalized for an
infection. All study patients with questionnaire results sug-
gestive of postpartum infection were identified. In the second
method, prospective inpatient surveillance was conducted by
infection control practitioners during the entire period, as
described (8).
Full-text ambulatory medical records and relevant hos-
pital records were reviewed for the 30-day postpartum
period for all patients identified through inpatient surveil-
lance or self-reported questionnaire results as described.
Resource use associated with infections during the 30-
day postpartum period was evaluated through review of
ambulatory records for patients with confirmed postpartum
infection. All free-text notes were reviewed, and encounters
for which the principal focus was the postpartum infection
were identified.
Table 1. Ambulatory record codes used to screen postpartum medical
encounters for infections
Screening code data source  Description  
Hospital and emergency room claims
ICD-9 diagnosis codesa
   670.02 Major puerperal infection, with 
postpartum complication
   670.04 Major puerperal infection, 
postpartum condition or 
complication
   599.0 Urinary tract infection
   674.34 Other obstetrical complication
   675.14 Postpartum breast abscess
   675.24 Postpartum nonpurulent mastitis 
   998.5 Postoperative infection
Ambulatory medical records
 COSTAR diagnosis codes
   DA140 Fever of unknown origin
   DC150 Cellulitis
   DC408 Abscess
   DH140 Mastitis
   DL101 Urinary tract infection
   DM153 Endometritis
   DR180 Wound infection
 COSTAR therapy or test codes
   RR240 Incision and drainage
   RT223 Bacterial culture taken
   RY828 Fever control instruction
   TB555 Blood culture
   TB800 Wound culture
Amoxacillin/clavulanate
Amoxicillin
Ampicillin
Cefuroxime
Cephalexin
Cephradine
Ciprofloxacin
Clindamycin
Dicloxacillin
Doxycycline
Erythromycin
Metronidazole
Trimethoprim-sulfamethoxazole
aHospital claims from delivery admission or any readmission within 30 days
or emergency department claims. ICD-9 = International Classification of
Diseases, 9th revision, clinical modification, 3rd edition.Research
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Predictors of Infection
Univariate analysis and logistic regression were used to
select predictors of infection by using data from the sample
of records with full-text ambulatory medical record review.
One thousand bootstrap samples of two-thirds of the data
were then used to simulate the model’s performance in a new
setting. The models were tested with the remaining data,
and measures of sensitivity, specificity, and predictive value
positive were extrapolated to the entire cohort (9). Selection
of the final model was based on predictive performance and
stability of the regression coefficient estimates. A separate
model was constructed by the same methods to specifically
predict surgical site infections, including endometritis,
among women who delivered by cesarean section.
Results
The study population consisted of 2,746 HPHC/HVMA
members who underwent 2,301 vaginal deliveries and 525
cesarean sections.  Ninety-five confirmed infections were
identified among the random sample of 100 women who had
at least one screening code and whose ambulatory medical
records were reviewed, plus the additional 210 women iden-
tified by patient questionnaire results or inpatient surveil-
lance. Extrapolation of the reviewed sample to the entire
source population predicted a total of 169 infections, for an
overall infection rate of 6.0% (95% confidence interval [CI]
5.1%, 6.9%). The extrapolated postpartum infection rates
were 7.4% after cesarean section (95% CI 5.3%, 10.0%) and
5.5% (95% CI 4.6%, 6.5%) after vaginal delivery.
Among women undergoing cesarean section, the site-
specific infection rates (number of infections/100 deliveries)
were mastitis 1.7% (0.8%, 3.2%), urinary tract infection 1.1%
(0.4%, 2.5%), surgical site infection (excluding endometritis)
3.4% (2.0%, 5.4%), and endometritis 0.8% (0.2%, 1.9%). Fol-
lowing vaginal delivery, the infection rates were mastitis
3.0% (2.4%, 3.8%), urinary tract infection 2.0% (1.4%, 2.6%),
episiotomy site infection 0.3% (0.2%, 1.9%), and endometritis
0.2% (0.1%, 0.5%) (Figure 1).
Approximately 94% of these infections were detected
after hospital discharge. For these post-discharge infections,
74% of patients did not return to the hospital where they
delivered for evaluation or treatment. 
Completeness of Surveillance
Four hundred ten (15%) of the 2,826 deliveries were
associated with at least one automated screening code for
postpartum infection. Screening codes identified 65 of the 71
patients who had verified postpartum infections identified
by either inpatient surveillance or self-reported question-
naire results. Using for comparison the extrapolated number
of postpartum infections among patients identified by auto-
mated code screening, plus all verified infections identified
by either prospective inpatient surveillance or self-reported
questionnaire screening, we determined the sensitivity of
ambulatory code screening for identifying patients with post-
partum infections to be 96% (95% CI 92%, 99%), specificity
to be 99% (95% CI 99%, 100%%), and predictive value posi-
tive to be 40% (95% CI 35%, 45%%). 
In comparison, both inpatient surveillance and self-
reported questionnaires missed most postpartum infections,
with sensitivities of 21% (95% CI 15%, 28%%) and 25% (95%
CI 19%, 32%), respectively. The sensitivity of inpatient sur-
veillance for detecting infections diagnosed during the initial
hospitalization or requiring readmission to the hospital,
however, was 100%.  
During the 30-day postpartum period, the 63 vaginal
deliveries complicated by postpartum infection among
women whose full-text ambulatory records were reviewed
were associated with 14 emergency department visits, 106
scheduled visits, and 36 urgent-care visits. Of these ambula-
tory encounters, 9 (64%) emergency department visits, 44
(42%) scheduled visits, and 21 (58%) urgent-care visits could
be verified as directly attributable to the postpartum infec-
tion. In addition, these infections resulted in 12 readmis-
sions to the hospital and 85 nonappointment encounters,
such as telephone calls or visits for laboratory tests. The 32
cesarean deliveries complicated by infection were associated
with 10 emergency department visits, 102 scheduled visits,
and 14 urgent-care visits. Of these ambulatory encounters, 8
(80%) emergency department visits, 74 (73%) scheduled vis-
its and 12 (86%) urgent-care visits were directly attributable
to the postpartum infection. These infections following cesar-
ean section resulted in 8 readmissions to the hospital and 40
nonappointment encounters. The 74 postpartum infections
that did not result in rehospitalization or emergency room
visits were associated with 68% of postpartum infection-
related ambulatory encounters. 
Predictors of Infection
Important predictors of postpartum infection included
rehospitalization within 30 days of delivery; cesarean versus
vaginal delivery; dispensing of antistaphylococcal antibiotics
(cephalexin, dicloxacillin, or both); diagnosis codes for masti-
tis, endometritis, and wound infection; and test codes for blood
and wound microbiology cultures (Table 2). Cesarean section,
although not statistically significant in this model, is included
because it is a significant predictor of surgical site infection
and endometritis. A cutoff probability of infection of  >0.20
yielded an expected sensitivity of 87% (95% CI 72%, 94%),
specificity of 97% (95% CI 96%, 98%), and predictive value
Figure 1. Extrapolated site-specific infection rates following vaginal
and cesarean delivery.
*Surgical site infections, excluding endometritisResearch
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positive of 55% (95% CI 41%, 68%). A cutoff probability of
infection of >0.40 yielded an expected sensitivity of 73% (95%
CI 59%, 84%), specificity of 98% (95% CI 98%, 99%), and pre-
dictive value positive of 64% (95% CI 52%, 77%) (Figure 2). 
A separate model was constructed to predict surgical
site infections among women who delivered by cesarean sec-
tion. This model included as important predictors of surgical
site infection ambulatory medical record test codes for blood
and wound culture and diagnosis codes for endometritis and
wound infection (Table 2). A cutoff probability of infection of
>0.25 yielded an expected sensitivity of 78% (95% CI 60%,
100%), specificity of 88% (95% CI 0%, 97%), and predictive
value positive of 75% (95% CI 23%, 92%). The stability of
this model in the simulation analysis was limited by the
small number of surgical site infections (22) among women
who had full-text ambulatory record review and who deliv-
ered by cesarean section.
Conclusion
Accurate assessment of the epidemiology of postpartum
infections has been hampered by the limitations of surveil-
lance systems for identifying these infections, particularly
infections detected after hospital discharge. In our study
population, use of inpatient and ambulatory surveillance
methods revealed that postpartum infections requiring med-
ical attention were common following both vaginal delivery
(5.5%) and cesarean section (7.4%). Mastitis and urinary
tract infections accounted for >80% of these infections. The
proportion of these infections directly attributable to health-
care practices cannot be determined from the information
available. Our study also does not address whether these
infections were associated with modifiable (and therefore
potentially avoidable) risk factors, for example, suboptimal
administration of perioperative prophylaxis during cesarean
section or bladder catheterization.
Nearly all postpartum infections became manifest after
hospital discharge (94%). Furthermore, most (74%) of these
postdischarge infections were diagnosed and treated entirely
in the ambulatory setting without the patients’ returning to
the hospital where they delivered for evaluation or treat-
ment, emphasizing the need for postdischarge surveillance
methods that are not dependent on hospital-based data.
Automated screening of ambulatory records was a sensi-
tive method for identifying postpartum infections. Inpatient
surveillance missed most infections that were diagnosed and
treated in the ambulatory setting. Patient self-reported
questionnaire results had limited sensitivity for detecting
infections, explained in part by the large number of nonre-
sponders. The questionnaire method was also more resource-
intensive than automated ambulatory code screening. It is
unclear whether questionnaire responders were representa-
tive of the entire postpartum patient population. 
Although surveillance based on automated screening of
ambulatory records depends on availability of ambulatory
Table 2. Predictors of postpartum infection used in the logistic regression models
Variable Odds ratio 95% confidence interval
Model 1: Urinary tract infection, mastitis, surgical site infection or episiotomy site infection following cesarean or vaginal delivery
Cesarean section 1.21 0.59-2.47
Antistaphylococcal antibiotics 1.89 1.02-3.53
Rehospitalization within 30 days of delivery 3.23 1.32-7.91
Ambulatory diagnosis code for mastitis, urinary tract 
infection, or endometritis
5.70 2.97-10.95
Ambulatory blood or wound culture 5.85 1.97-17.84
Hospital or emergency department diagnosis code for 
mastitis, urinary tract infection, or other obstetrical 
complications
*
Model 2. Surgical site infections (including endometritis) following cesarean section
Ambulatory blood or wound culture 9.17 2.44-34.41
Ambulatory diagnosis code for endometritis or wound 
infection
*
*In the prediction model, any woman with one or more of these codes was given an automatic probability of infection of 1.0 to maintain stability of the model
during bootstrap sampling.
Figure 2. Sensitivities and predictive value positives of differing cut-
off probabilities of infection based on 1,000 bootstrap samples. A cut-
off probability of infection of >0.20 yielded a sensitivity of 87% and a
predictive value positive of 55%. A cutoff probability of >0.40 yielded
a sensitivity of 73% and a predictive value positive of 64%. Research
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diagnoses, tests, and pharmacy information, an increasing
number of patients receive their health care through man-
aged care organizations that routinely collect this informa-
tion for administrative purposes. The specific diagnosis and
test screening codes used for this study were based on a cod-
ing system unique to this HMO; however, similar informa-
tion could be obtained by using an ICD-9-based outpatient
claims database (International Classification of Diseases,
9th revision, clinical modification, 3rd edition). In principle,
this method or a modification of it should be applicable for
most of the U.S. population who have health insurance that
includes pharmacy benefits. An additional limitation of this
study is that the accuracy of the extrapolated infection rates
depends upon the assumption that very few infections occur
among postpartum women with none of the screening codes.
This assumption is supported, however, by the finding that
even among women identified as potentially infected
through patient questionnaire results and inpatient surveil-
lance, very few infections were confirmed through medical
record review without at least one screening code. 
In conclusion, our results indicate that postpartum
infections requiring medical attention are common and that
most postpartum infections occur after hospital discharge, so
that use of routine inpatient surveillance methods alone will
lead to underestimation of postpartum infection rates. Use of
automated information routinely collected by HMOs and
insurers allows efficient identification of women who are
very likely to have postpartum infections that are not
detected by conventional surveillance. Information resulting
from more complete surveillance could be used to identify
settings with unusually high or low infection rates to iden-
tify practices associated with lower infection rates. This
information could then be used to focus, motivate, and assess
the effectiveness of practice changes aimed at improving
infection rates in all settings. Additional research is needed
to evaluate the generalizability of this surveillance method-
ology to other health-care provider and insurer systems
especially those that are entirely claims based, and to assess
resource utilization associated with these infections. 
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